Primary hyperparathyroidism: Biochemical markers and bone mineral density at multiple skeletal sites in Danish patients

Bone

Volumn 21, Issue 1, 1997, Pages 93-99

  Christiansen, Peer ^a   Steiniche, T ^b   Brixen, K ^a   Hessov, I ^a   Melsen, F ^b   Charles, P ^a   Mosekilde, Le ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University Institute of Pathology Arhus   (Denmark)

Author keywords

Biochemical bone markers; Bone mineral density; Densitometry; Primary hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; ENZYME ACTIVITY; FEMALE; FOREARM; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; SPINE;

EID: 0030820669     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00078-1     Document Type: Article

References (44)

1. Bilezikian, J. P., Silverberg, S. J., and Gartenberg, F. Clinical presentation of primary hyperparathyroidism. In: Bilezikian, J. P., Levine, M. A., and Marcus, R., Eds. The Parathyroids. New York: Raven; 1994; 457-469.
2. Block, M. A., Dailey, G. E., and Muchmore, D. E. Bone demineralization, a factor of increasing significance in the management of primary hyperparathyroidism. Surgery 106:1063-1068; 1989.
3. Brixen, K., Nielsen, H. K., Eriksen, E. F., Charles, P., and Mosekilde, L. Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: Comparison to serum total alkaline phosphatase and serum bone Gla-protein [see comments]. Calcif Tissue Int 44:93-98; 1989.
4. Brockstedt, H., Christiansen, P., Mosekilde, L., and Melsen, F. Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone 16:109-117; 1995.
5. Christiansen, P., Steiniche, T., Brockstedt, H., Mosekilde, L., Hessov, I., and Melsen, F. Primary hyperparathyroidism: Iliac crest cortical thickness, structure, and remodeling evaluated by histomorphometric methods. Bone 14:755-762; 1993.
6. Christiansen, P., Steiniche, T., Mosekilde, L., Hessov, I., and Melsen, F. Primary hyperparathyroidism: Changes in trabecular bone remodeling following surgical treatment - evaluated by histomorphometric methods. Bone 11: 75-79; 1990.
7. Christiansen, P., Steiniche, T., Vesterby, A., Mosekilde, L., Hessov, I., and Melsen, F. Primary hyperparathyroidism: Iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 13:41-49; 1992.
8. Dauphine, R. T., Riggs, B. L., and Scholz, D. A. Back pain and vertebral crush fractures: An unemphasized mode of presentation for primary hyperparathyroidism. Ann Intern Med 83:365-367; 1975.
9. Dawson-Hughes, B., Dallal, G. E., Krall, E. A., Sadowsky, L., Sahyoun, N., and Tannenbaum, S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323:878-883; 1990.
10. Delling, G. Bone morphology in primary hyperparathyroidism - a qualitative and quantitative study of 391 cases. Appl Pathol 5:147-159; 1987.
11. Delmas, P. D., Stenner, D., Wahner, H. W., Mann, K. G., and Riggs, B. L. Serum bone gla protein increases with aging in normal women: Implications for the mechanism of age related bone loss. J Clin Invest 71:1316-1321; 1983.
12. Eriksen, E. F., Mosekilde, L., and Melsen, F. Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone 7:213-221; 1986.
13. Frost, H. M. Some effects of basic multicellular unit-based remodelling on photon absorptiometry of trabecular bone. Bone Miner 7:47-65; 1989.
14. Fujimoto, D., Suzuki, M., Uchiyarna, A., Miyamoto, S., and Inoue, T. Analysis of pyridinoline. A cross-linking compound of collagen fibers in human urine. J Biochem 94:1133-1136; 1983.
15. Gonchoroff, D. G., Branum, E. L., Cedel, S. L., Riggs, B. L., and Obrien, J. F. Clinical evaluation of high-performance affinity chromatography for the sep-aration of bone and liver alkaline phosphatase isoenzymes. Clin Chim Acta 199:43-50; 1991.
16. Haraldsdóttir, J., Holm, L., Jensen, J. H., and Møller, A. Danskernes kostvaner 1985 - I Hovedresultater. Søborg, Denmark: Milj¢ministeriet, Levnedsmiddelstyrelsen; 1986.
17. Hesp, R., Tellez, M., Davidson, L., Elton, A., and Reeve, J. Trabecular and cortical bone in the radii of women with parathyroid adenomata: A greater trabecular deficit, with a preliminary assessment of recovery after parathyroidectomy. Bone Miner 2:301-310; 1987.
18. Keiding, R., Hörder, M., Gerhardt, W., Pitkänen, E., Tenhunen, R., and Strömme, J. H. Recommended methods for the determination of four enzymes in the blood. Scand J Clin Lab Invest 33:291-306; 1974.
19. Kochersberger, G., Buckley, N. J., Leight, G. S., Martinez, S., Studenski, S., Vogler, J., and Lyles. K. W. What is the clinical significance of bone loss in primary hyperparathyroidism? Arch Intern Med 147:1951-1953; 1987.
20. Larsson, K., Lindh, E., Lind, L., Persson, I. and Ljunghall, S. Increased fracture risk in hypercalcemia. Bone mineral content measured in hyperparathyroidism. Acta Orthop Scand 60:268-270; 1989.
21. Larsson, K., Ljunghall, S., Krusemo, U. B.. Naessen, T., Lindh, E., and Persson, I. The risk of hip fractures in patients with primary hyperparathyroidism: A population-based cohort study with a follow-up of 19 years. J Intern Med 234:585-593; 1993.
22. Leppla, D. C., Snyder, W., and Pak, C. Y. Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism. Invest Radiol 17:604-606; 1982.
23. Martin, P., Bergmann, P., Gillet, C., Fuss, M., Kinnaert, P., Corvilain, J., and Van Geertruyden, J. Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 146:689-691; 1986.
24. Mautalen, C., Reyes, H. R., Ghiringhelli, G., and Fromm, G. Cortical bone mineral content in primary hyperparathyroidism. Changes after parathyroidectomy. Acta Endocrinol (Copenh) 111:494-497; 1986.
25. Mazess, R. B. Fracture risk: A role for compact bone. Calcif Tissue Int 47:191-193; 1990.
26. Melkko, J., Niemi, S., Risteli, L., and Risteli, J. Radioimmunoassay of the carboxyterminal propeptide of human type-I procollagen. Clin Chem 26:1328-1332; 1990.
27. Melsen, F. and Mosekilde, L. Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res 26:99-102; 1978.
28. Melton, L. J., Atkinson, E. J., O'Fallon, W. M., and Heath, H. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 152:2269-2273; 1992.
29. Parfitt, A. M., Kleerekoper, M., Rao, D., Stanciu, J., and Villanueva, A. R. Cellular mechanisms of cortical thinning in primary hyperparathyroidism (PHPT) [abstract]. J Bone Miner Res 2(Suppl. 1):384; 1987.
30. Parisien, M., Silverberg, S. J., Shane, E., De La Cruz, L., Lindsay, R., Bilezikian, J. P., and Dempster, D. W. The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930-938; 1990.
31. Peacock, M., Horsman, A., Aaron, J. E., Marshall, D. H., Selby, P. L., and Simpson, M. The role of parathyroid hormone in bone loss. In: Christiansen, C., Arnaud, C. D., Nordin, B. E. C., Parfitt, A. M., Peck, W. A., and Riggs, B. L., Eds. Osteoporosis. Proceedings of the Copenhagen International Symposium on Osteoporosis, June 3-8, 1984. Aalborg, Denmark: Aalborg Stiftsbogtrykkeri; 1984; 463-467.
32. Pfeilschifter, J., Siegrist, E., Wuster, C., Blind, E., and Ziegler, R. Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. Acta Endocrinol (Copenh) 127:319-323; 1992.
33. Phillips, J. R., Williams, J. F., and Melick, R. A. Prediction of the strength of the neck of the femur from its radiological appearance. Biomed Eng 10:367-372; 1975.
34. Price, P. A. and Nishimoto, S. K. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 77:2234-2238; 1980.
35. Recker, R. R., Kimmel, D. B., Parfitt, A. M., Davies, K. M., Keshawarz, N., and Hinders, S. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 3:133-144; 1988.
36. Richardson, M. L., Pozzi Mucelli, R. S., Kanter, A. S., Kolb, F. O., Ettinger, B., and Genant, H. K. Bone mineral changes in primary hyperparathyroidism. Skel Radiol 15:85-95; 1986.
37. Risteli, J., Niemi, S., Elomaa, I., and Risteli, L. Bone resorption assay based on a peptide liberated during type I collagen degradation. J Bone Miner Res 6(Suppl. 1):A670; 1991.
38. Rockoff, S. D., Sweet, E., and Bluestein, J. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res 3:163-175; 1969.
39. Rosalki, S. B. and Foo, A. Y. Two new methods for separating and quantifying bone and liver alkaline phasphatase isoenzyme in plasma. Clin Chem 30:1182-1186; 1984.
40. Seeman, E., Wahner, H. W., Offord, K. P., Kumar, R., Johnson, W. J., and Riggs, B. L. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 69:1302-1309; 1982.
41. Silverberg, S. J., Shane, E., De La Cruz, L. et al. Skeletal disease in primary hyperparathyroidism [see comments]. J Bone Miner Res 4:283-291; 1989.
42. van Doom, L., Lips, P., Netelenbos, J. C., and Hackeng, W. H. Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism. Bone Miner 23: 233-242; 1993.
43. Vesterby, A., Mosekilde, L., Gundersen, H. J., Melsen, F., Holme, K., and Sorensen, S. Biologically meaningful determinants of the in vitro strength of lumbar vertebrae. Bone 12:219-224; 1991.
44. Wilson, R. J., Rao, S., Ellis, B., Kleerekoper, M., and Parfitt, A. M. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 109:959-962; 1988.